6505--FY23 HTG Radiosotopes Nuclear Medicine RFQ Ammend 1 Answer to questions
Overview
- Response deadline
- 1:00 PM UTC−04:00
- Posted
- September 15, 2022
- Notice type
- Combined Synopsis/Solicitation
Notice details
- Office
- 245-NETWORK CONTRACT OFFICE 5 (36C245)
- Place of performance
- Department of Veterans Affairs Huntington VAMC Warehouse 1540 Spring Valley Dr, Huntington, WV, 25704
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C24523Q0001
- Notice ID
- 38980fb7e1334012aa18a441667e5540
Description
The Purpose of Ammend 1 is to answer questions and extend closing date. Q1. On line 0011 in the product list for Tc-99m Sestamibi qty 77000, is this annual qty or provide new annual qty?- A1. UD is changed from UD to MU-MCI, Yes annual qty and no qty change, see attached RFQ On line 0009 for Tc-99m Oxidronate UD is listed for a qty of 6800 doses, is this mCi and is this annual qty or provide new qty? A2. UD is changed from UD to MU-MCI, Yes annual qty and no qty change. see attached RFQ Q3. Can RFQ close be extended to next week? A3. No, it extended to close 9/16/22 @1pm EST. Attachments (2): Revised RFQ Excel spreadsheet
Award Overview
Possible prior contract
Inferred, not confirmedInferred, not confirmed. Matched by agency, NAICS, place of performance and end-date proximity. This is a candidate, not the contractor of record.
Dollar amounts are not shown for inferred matches because the link is heuristic. Open the award below to check it.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C24523Q0001- Combined Synopsis
- 2×Combined SynopsisCurrentSep 8, 2022
6505--FY23 HTG Radiosotopes Nuclear Medicine RFQ Ammend 1 Answer to questions
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36C24523Q0001
Archive Date
Sep 26, 2022
Office Address
LINTHICUM, MD, 21090